Filing Details
- Accession Number:
- 0001209191-11-012711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-25 13:01:08
- Reporting Period:
- 2011-02-23
- Filing Date:
- 2011-02-25
- Accepted Time:
- 2011-02-25 13:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1292162 | Bryant Steven Porter | 3280 Bayshore Boulevard Brisbane CA 94005 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-23 | 7,000 | $15.40 | 67,957 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-23 | 7,000 | $35.94 | 60,957 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-02-23 | 7,000 | $0.00 | 7,000 | $15.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,969 | 2016-06-30 | No | 4 | M | Direct |
Footnotes
- These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $35.68 to $36.18 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exercisable.
Billionaire Hedge Funds
